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ORIGINAL INVESTIGATION
Older Adults and Forgoing Cancer Screening
“I Think It Would Be Strange”
Alexia M. Torke, MD, MS; Peter H. Schwartz, MD, PhD; Laura R. Holtz, BS;
Kianna Montz, MA; Greg A. Sachs, MD
Importance: Although there is a growing recognition
that older adults and those with extensive comorbid con-
ditions undergo cancer screening too frequently, there
is little information about patients’ perceptions regard-
ing cessation of cancer screening. Information on older
adults’ views of screening cessationwould be helpful both
for clinicians and for those designing interventions to re-
duce overscreening.
Objective: To obtain a deeper understanding of older
adults’ perspectives on screening cessation and their ex-
periences communicatingwith clinicians about this topic.
Design: Semistructured interview study.
Setting: Senior health center affiliated with an urban
hospital.
Participants: We interviewed 33 older adults present-
ing to a senior health center. Their median age was 76
years (range, 63-91 years). Of the 33 participants, 27were
women; 15 were African American, 16 were white, 1 was
Asian, and 1 was American Indian.
Main Outcome Measures: We transcribed audio re-
cordings of interviews and analyzed them using meth-
ods of grounded theory to identify themes and illustra-
tive quotes.
Results: Undergoing screening tests was perceived by
participants as morally obligatory. Although many saw
continued screening as a habit or custom not involving
any decision, cessation of screening would require a ma-
jor decision. Many asserted that they had never dis-
cussed screening cessation with their physicians or con-
sidered stopping on their own; some reported being upset
when their physician recommended stopping. Al-
though some would accept a physician’s strong recom-
mendation to stop, others thought that such a physi-
cian’s recommendationwould threaten trust or lead them
to get another opinion. Participants were skeptical about
the role of statistics and the recommendations of gov-
ernment panels in screening decisions but were more fa-
vorable toward stopping because of the balance of risks
and benefits, complications, or test burdens.
Conclusions and Relevance: For many older adults,
stopping screening is a major decision, but continuing
screening is not. A physician’s recommendation to
stopmay threaten patient trust. Effective strategies to re-
duce nonbeneficial screening may include discussion
of the balance of risks and benefits, complications, or
burdens.
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S CREENING FOR CANCER IS PARTof standardmedical care, andeducational and advocacy ef-forts for clinicians and thepublic aim at increasing can-
cer screening rates.1However, the risks and
benefits of screening are altered by co-
morbid illness, poor functional status, or
advanced age.2-5 Positive results from
screening tests lead to a cascade of diag-
nostic and treatment interventions that
carry risk.2 The risks may be amplified by
conditions such as dementia, whichmake
compliance with testing and treatment
regimens more difficult.6 Recent studies
suggest that cancer screening is con-
ducted in many patients who are un-
likely to benefit from such testing be-
cause of either advanced age or serious
illness.7-10
Drawing on these studies, some ex-
perts have called for efforts to reduce can-
cer screening in populations where it is
either nonbeneficial or potentially harm-
ful. For example, the US Preventive Ser-
vices Task Force3 has begun to issue rec-
ommendations for age-based stopping
points for some disease screening, such as
stopping routine screening for colon can-
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cer at age 75 years or cervical cancer at age 65 years.11
Organizations such as the American Geriatrics Society12
have recommended an individualized approach to screen-
ing decisions for older adults.
Despite the growing consensus that we need to curb
overscreening, changing patient and physician behavior
will be difficult in light of older adults’ highly favorable
views of screening. One study13 found that most resi-
dents of a retirement community planned to continue
screening throughout their lives, and 43% would con-
tinue screening even against a physician’s recommen-
dation. A national telephone survey of adults aged 50
years or older found that only 9.8% had plans to stop
screening. These plans were unrelated to self-reported
health status or age, with individuals aged 70 years or
older no more likely to stop than those aged 50 to 69
years.14
These attitudes are similar to those seen in Ameri-
cans more generally; most Americans surveyed see
screening as an undisputed good and fail to recognize
how screening tests can be harmful or nonbenefi-
cial.15,16 Positive attitudes may help motivate individu-
als to undergo screening when their health status or age
makes screening tests beneficial, but when they are
older or ill, these same attitudes and limitations in un-
derstanding may make it hard for them to accept rec-
ommendations to stop screening.
Despite the data on older adults’ highly positive views
of screening, there is little information about how they
respond to recommendations to stop screening or what
considerations factor into their decisions. We con-
ducted this study to examine older adults’ beliefs and opin-
ions about cancer screening and their experiences dis-
cussing screening cessation with their physicians. Our
goal is to provide information for clinicians having such
discussions and to guide the design and implementa-
tion of interventions aimed at reducing overscreening.
We conducted semistructured interviews about cancer
screening decisions with older adults seeking care at a
senior health clinic. We chose this open-ended ap-
proach because little is known about how older adults
will react to recommendations to stop screening or what
variables may be most important to their decisions.
METHODS
SETTING AND PARTICIPANTS
This study was conducted in a senior health center affiliated
with an urban public hospital and was approved by the Indi-
ana University Institutional Review Board. Potential partici-
pants were adults aged 60 years or older attending regularly
scheduled primary care or specialtymemory practice clinic vis-
its. Participants could have normal cognition or mild cogni-
tive impairment, as documented after comprehensive evalua-
tion in a memory clinic. These persons were included if their
Mini-Mental State Examination (MMSE)17 score was 20 or
higher. We included some persons with cognitive impairment
becausemild cognitive impairment and dementia affect the risk-
benefit ratio of screening.6,18 All persons were judged by their
treating physician to have the capacity to give informed con-
sent for study participation and had beenmaking decisions for
their own health care, including cancer screening. Partici-
pants were ineligible if they had an MMSE score below 20 or
did not speak English.
During the recruitment period, research assistants at-
tended clinic sessions and considered all patients attending the
session for enrollment. Medical records were reviewed to de-
termine eligibility and we requested permission to enroll from
each participant’s physician.
MEASUREMENTS
Data collection included demographic variables, information on
chronic health conditions, and recent experiences with cancer
screenings and vaccinations (Table 1). Semistructured face-to-
face interviews were conducted in private clinic rooms by 1 of 2
trained research assistants (see eAppendix; http://www
.jamainternalmed.com). The first section included open-ended
questions about patient perceptions and recent experienceswith
screening decisions. The second section probed a list of poten-
tial decision-making factors, such as physician recommenda-
tions, statistical data about the test, and hypothetical conditions
such as living in a nursing home. Each person was asked to re-
spond to the potential impact of the factor on his or her decision-
making process. Audio recordings of the interviews were tran-
scribed for analysis.Transcribed interviewsandcodeswere entered
into NVivo software (version 8; QSR International) to allow for
sorting of the coded segments of text.
STATISTICAL ANALYSIS
We conducted a thematic analysis, informed by methods of
grounded theory.19 This approach relies on careful reading of
the text to identify major themes in the data. The first 5 inter-
views were coded by all investigators using open and axial cod-
ing.19,20 During the initial reading, phrases, sentences, or lon-
ger segments of text were identified by the investigator and
labeled (open coding). Codes were based on the important con-
cepts that emerged from the interviews rather than on the in-
terview questions or other predefined categories. Team meet-
ings were used to discuss the emerging codes. After the open
Table 1. Characteristics of the 33 Study Participants
Characteristic Data
Age, mean (SD), y 75.7 (7.3)
Age, median (range), y 76 (63-91)
Female sex, No. (%) 27 (82)
Race, No. (%)
African American 15 (45)
White 16 (48)
American Indian 1 (3)
Asian 1 (3)
Educational level, mean (SD), y 11.7 (3.2)
Mild cognitive impairment, No. (%) 14 (42)
Self-assessed socioeconomic status, No. (%)
Comfortable 5 (15)
Enough to make ends meet 15 (45)
Not enough 13 (39)
Chronic medical conditions, mean (SD), No. 2.5 (1.4)
Personal history of cancer, No. (%) 2 (6)
Screening or vaccination completed, No. (%)
Colon cancer within past 5 y 19 (58)
Breast cancer within past 2 y (in women) 21/27 (78)
Cervical cancer within past 3 y (in women) 6/27 (22)
Prostate cancer within past 2 y (in men) 2/6 (33)
Influenza vaccination within past 1 y 23 (70)
Pneumococcal vaccine polyvalent ever 22 (67)
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coding process, the codes were organized into larger catego-
ries to reflect the major themes (axial coding). Subsequent in-
terviews were read by all investigators but coded in detail by 1
of 3 investigators (A.M.T., P.H.S., or G.A.S.). At each teammeet-
ing, we discussed emerging themes and selected representa-
tive quotes. Subsequent interviews led to revision and refine-
ment of the themes. Minutes from these meeting were used by
one of us (A.M.T.) to write descriptive memos for each theme.
We used several strategies to establish trustworthiness of
the data. Interviews were read by all investigators; disagree-
ments about the meaning of themes or codes were discussed
at team meetings and resolved by consensus. We included in-
vestigators with varied backgrounds, including a physicianwith
a doctorate in philosophy (P.H.S.), a geriatrician (G.A.S.), and
a general internist (A.M.T.) and nonphysician research staff with
backgrounds in education (K.M.) and health care compliance
(L.R.H.). Conducting interviews until theme saturation was
reached also improved the trustworthiness of the data by en-
suring that key themes had been successfully identified.
RESULTS
Of 42 potential participants, 33 patients enrolled, 2 were
not approachedbecause the physician didnot approve par-
ticipation, 3didnotdemonstrateunderstandingof the study
during the consent process, and 4 refused to participate.
The participants’ median age was 76 years (range, 63-91
years). Twenty-seven of 33 were women; 15 were African
American, 16 were white, 1 was Asian, and 1 was Ameri-
can Indian (Table 1). The mean length of the interviews
was 25minutes (range, 13-40minutes).We found that pa-
tients considered screening amoral obligation and did not
consider continuing screening as a decision. Few had dis-
cussed screening cessation with a physician.
OBLIGATION TO UNDERGO SCREENING
Patients’ highly favorable views of screening were re-
flected in the many reasons to screen that they sponta-
neously expressed (Table 2), but overriding these spe-
cific reasons was a sense that screening was a moral
obligation. For instance, an 84-year-old woman de-
scribed the choice between stopping and continuing
screening:
I think I should, because [stopping] would be the same as me taking
my life. And that’s a sin.
Screening was also equated directly with health and
life:
I know that I need that done because I love my life, you know. I want
to live.
SCREENING NOT A DECISION
The continuation of screening typically was character-
ized not as a decision but as something done automati-
cally. A 91-year-old woman discussing her prior screen-
ing experiences stated,
Whenever we were told we were supposed to do something, I just, you
know, did it.
For some patients, continued screening occurred as
a matter of routine or habit, sometimes in response to a
physician prompt, a form letter, or other brief re-
minder. Some expressed an expectation for an annual test.
One 75-year-old woman said that she decided to have a
mammogram “because I was getting them every year.”
Others simply went along with the plan for screen-
ing with little discussion or understanding of the pur-
pose of the test:
Interviewer: And what went into the decision to have the mammo-
gram done?
Participant: I’m not sure, other than it was a good thing to have on
record.
When physicians recommended continuing screen-
ing, patients generally accepted the recommendationwith-
out further questioning or discussion:
Doc said I needed it, and I . . . told them to go ahead and do it.
LIMITED COMMUNICATION ABOUT SCREENING
Many participants stated that they had never discussed
stoppingwith a physician or considered stopping on their
own. Patients described discussions about both continu-
ing and stopping screening as being very brief and con-
taining little information. Many did not express any dis-
comfort with this, suggesting that they did not have an
expectation of receiving more information:
Interviewer: Can you tell me about what the doctor said to you the last
time you made a decision about cancer screening?
Participant: Just recommended a mammogram.
Interviewer: [D]id you discuss the benefits or the harms of the test?
Participant: No.
Interviewer: Was there anything that the doctor said or did that you
found especially helpful during that conversation?
Participant: No, not really. . . . Just seemed unconcerned and just
a . . . typical test.
Table 2. Factors Spontaneously Raised by Participants
That Would Lead to Screening
Factor Quotation From Participant
Desire to live longer I want to stay on this earth as long as
possible, and the best way to do it is to
take these tests.
Desire to prepare for
end of life
Because if I’ve got cancer. . .I want to know
so that I can get ready with the Lord to go.
Desire to gain
knowledge
I want to know. And if I didn’t keep getting
them, I wouldn’t know.
Desire to obtain
treatment
Try to get it taken care of, or let Dr S know
about it.
Early detection of
cancer
I would want them to do it as soon as I could
for fear that if I did have it, they would be
able to catch it before it spread too far.
Habit or custom Because I was getting [mammograms] every
year. Well, I’ve been having them done
periodically.
Fear of cancer I feel like cancer’s about the worst thing you
could have, and I think it would go over all
the rest of [my other medical conditions].
Reassurance It would give me peace of mind.
Racial differences in
risk
I feel like all black women should have it
because different things happen to us.
Family history I just feel like it’s something I need to
do. . .because I have a family history of
cancer.
JAMA INTERN MED/VOL 173 (NO. 7), APR 8, 2013 WWW.JAMAINTERNALMED.COM
528
©2013 American Medical Association. All rights reserved.
Downloaded From: http://archinte.jamanetwork.com/ by a Indiana University School of Medicine User  on 03/18/2014
An 83-year-old woman described accepting her phy-
sician’s recommendation to stop screening mammogra-
phy after being given very little information:
She just looked at my paper and said she didn’t think I needed them
anymore.
Only 1 patient whose physician recommended against
screening because of the patient’s age was upset by the
recommendation.
POTENTIAL FACTORS IN DECISION MAKING
Some patients spontaneously mentioned factors that
would influence a decision to forgo screening, such as
poor health or the burden on others (Table 3). During
the interview,we also asked participants to consider some
factors that may influence their screening decisions; we
describe several that elicited especially strong reactions
(see Table 4 for all factors).
Active Discouragement of Screening by Physician
When asked how they would respond if their physician
recommended against a cancer screening test, many par-
ticipants said they would question the physician’s rec-
ommendation or seek a second opinion:
I think it’d be strange for a doctor to advise not having that done, but
I would take his word for it too, and ask why.
Some participants expressed disbelief that a physi-
cian would ever recommend stopping cancer screening:
You’ve been told something, this cancer can be prevented if you have
these tests and then all of a sudden he tells me that I wouldn’t benefit
from that anymore. I couldn’t see why.
In contrast, a few participants voiced unquestioning
acceptance of the physician’s recommendation either to
screen or to forgo screening.
Government Panels
There were many negative responses to recommenda-
tions from experts or government panels. Common
themes included the fact that guidelines for cancer
screening and other healthful behaviors had changed in
the past:
I have heard so much of the government changing their minds on
this . . . just like for example, coffee’s not good for you, then coffee’s
right for you, you know . . . I don’t have toomuch faith in some of them.
Others raised concerns about financial incentives for
the government to recommend against screening.
Statistics
Several participants expressed the opinion that statistical
information is not relevant to individual decisionmaking:
I would not consider myself part of the statistics, and I think each in-
dividual person is different.
Others expressed optimism that even if the chance of
benefit was low, they might be the one to benefit from
the test.
Burdens and Benefits
Many participants expressed that they would be con-
vinced to stop screening owing to the burdens of the test
or if the burdens outweighed the benefits. Several brought
up their experiences with colonoscopy as an example of
a highly burdensome procedure:
I don’t want to, mainly because I don’t like that stuff you have to drink
and then the fact that you have to spend so many hours on the toilet.
COMMENT
Our study of older adults attending an urban senior health
center demonstrated that these adults felt a strongmoral
obligation to continue cancer screening. Although par-
ticipants viewed undergoing screening as not a decision—
because it is automatic, recommended, ormorally obliga-
tory—many did see cessation of screening as requiring
a major decision. These findings emphasize how public
health campaigns are working well to communicate the
health benefits of screening, so much so that patients do
not even consider undergoing screening as something to
decide. Patients expect clinicians, like the rest of the health
care establishment, to encourage and endorse screen-
ing. Given the steady drumbeat of physicians and pub-
lic health campaigns in favor of screening, patients may
find a recommendation to stop, once they reach a cer-
tain age, to be jarring. Our finding of a positive attitude
toward screening is consistentwith previous research find-
ingwidespread support for screening, amongUS adults,15
older adults in the United States,13,14 and physicians.21
Publichealtheducationandphysicianendorsementmay
have created ahighdegree of “momentum” for continuing
screening, even in situations in which the benefits may no
Table 3. Reasons to Forgo Screening Spontaneously Raised by Participants
Factor Quotation From Participants
Poor health or advanced age If I’m 90 and I’m crippled up with arthritis, forget it. If I’m 85 and I’m crippled up with arthritis and I have
memory problems and I can’t talk to people, forget it.
Screening no longer appropriate They didn’t do a Pap smear because there wasn’t nothing to check. That’s why I don’t have it anymore.
Intergenerational equity There’s no real point to it, and I do think there is getting to be a burden on senior citizens who can’t really
do very much to help, and they are costing more time and money to be spent on their problems, when
small kids aren’t getting as much help as they need.
Burden on family and others I don’t like to be a burden or an interference with my son’s life because he has to learn how to live as an
adult without his wife.
Lack of family history I don’t have no history of cancer at all, of any kind, in my family. That’s what influences my decision.
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longeroutweigh the risksorburdens. In this case, anactive
forcemaybeneededtoslowdownorstopthebehavior.Adults
consideringcancer screening tests report that cliniciansare
theirmost important source of information.22 Some of our
findingsmayguide thecraftingofmessages that areaccept-
abletopatientsandeffectiveinreducingunnecessaryscreen-
ing. For example, framing the conversation in terms of
increasingburdensinrelationtobenefitsseemsmostaccept-
able to patients andmaymaintain or promote trust. This is
likely tobemoreeffective thancitingstatisticsabout thepa-
tient’s likelihoodofbenefitingfromthetestornationalguide-
linesaboutwhentostopscreening.Inourstudy,whenasked
howtheywould respond toaphysician’s recommendation
to stop screening, many participants said that they would
questiontherecommendationorseekasecondopinion,and
someexpressedthebelief thataphysicianwouldnevermake
sucharecommendation.Althoughsomeparticipantsstated
thatahypothetical recommendationtostopwouldthreaten
their trust, suchrecommendationsmightbemoreeffective
in the contextof anestablished trusting relationshipwitha
primary care provider.
We found that patients were skeptical and suspi-
cious about the recommendations of experts and gov-
ernment panels to stop screening, expressing the con-
cern, for example, that such recommendations were
formulated to save money. Patients also expressed lim-
ited trust in statistics. A panel’s recommendation against
screening may be based on complex statistics on esti-
mated remaining life expectancy, risks, and rates of ad-
verse effects, but our findings demonstrate the danger of
assuming that patients will consider these statistical data
helpful. Although some experts recommend that physi-
cians incorporate information about individual pa-
tients’ prognoses into their screening recommenda-
tions,23 the same distrust and lack of understanding of
statistics may keep such approaches from being persua-
sive. Patients may well believe that the statistics simply
do not apply to them, as one of our participants said.
In contrast, our participants seemed to respond well
to the idea that screening does not make sense if the bur-
dens—including pain, time requirements, or stress—
are expected to outweigh the benefits. This way of ex-
plaining why the physician is no longer recommending
screening seemed to hold some promise for both pa-
tient understanding and acceptance. Of note, the bur-
dens of colonoscopywere repeatedly cited as reasons not
Table 4. Factors to Consider in Forgoing Screening
Factor
Quotations From Participants
Factor Would Lead to Forgoing Screening
Factor Would Not Lead
to Forgoing Screening
Limited life expectancy Oh yeah. That would dictate whether the test would be important to
take or not.
No, doctors don’t know how long you’re gonna live.
Other medical conditions With all that’s wrong with you, I think I would get tired of going and
getting something, because by that time. . .I’d have to have
somebody to take me. . .I think I would just give up.
None
Severe memory problems If your memory’s gone, and everything else, I’m thinking, there’s no
point in having all those tests done.
None
Living in a nursing home If I’m in a nursing home and the screening tests are coming up, no, I
wouldn’t bother with it because my life is going to end. . .I’m
going to die anyways.
I don’t think none of that would influence
me.. . .They always want you to go to nursing
homes.
Burdens of the test or
burdens outweighing
benefits
I used to work at a hospital where we did colonoscopies and I don’t
know what they do now for cleaning out the colon, but it wasn’t
pleasant when I worked down there. . .drinking all that Colyte or
whatever.
None
Risks If they told me I was going to come in to some danger and I’m
already not that well. . .I just say no, I don’t want to have it.
They do tell you [about the risks]. And I think they
should tell patients. . .it could happen. . .but
usually don’t.
I wouldn’t want to hear any risk.
Lack of benefit or life
expectancy not long
enough to benefit
Why should I submit myself if I will not benefit from it? None
Recommendation by
independent experts or
government panels
None I have heard so much of the government changing
their minds on this. . .just like for example,
coffee’s not good for you, then coffee’s right for
you, you know. . .I don’t have too much faith in
some of them.
Statistics that help explain
what happened to others
who underwent the test
None I would not consider myself part of the statistics,
and I think each individual person is different.
What happens to someone else may not happen to
me. . .I might be the one that would be helped.
Physician actively
discouraging patient from
undergoing the test
If my doctor said that he didn’t think I’d benefit, I’d take his word. I think I might seek another doctor, get a second
opinion.
Lack of insurance coverage That might entail a lot more than I can afford. It’s important to me, yes it is very important to me.
But if my health was really at stake, I’d take a
chance on maybe if they’d pay for it a little at a
time, even, I would want to have it.
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to continue with this screening test as the patient aged.
Some participants also reported that they would not wish
to keep undergoing screening if they lived in a nursing
home, perhaps because such residence was seen bymany
of them as a proxy for imminent death and a low quality
of life. In this setting, the benefits of life extensionmight
seem limited, justifying cessation of screening.
The emphasis on decreasing benefits and increasing
risks of screening may help patients to understand that
at certain ages, orwith certain comorbid conditions, other
goals of caremay have a higher payoff for improving qual-
ity of life and even extending life. Just as the public health
andmedicalmessage to patients is that screening is a wise
and admirable choicewhen they aremiddle aged and oth-
erwise healthy, somustmessages explainwhy not screen-
ing, and focusing on other aspects of care, may be wise
and admirable when patients are older or ill.
This study has several limitations. It was conducted in
a single public hospital setting and cannot be generalized
to other settings. A high proportion of participants were
female. Most participants were considering the cessation
of screening tests as a hypothetical rather than real choice.
Patient responsemay have been different if in fact each pa-
tient’s personal physician had proposed stopping screen-
ing tests.We deliberately included some participants with
known mild cognitive impairment who may have had di-
minishedunderstanding of these issues.However, such in-
dividualswere still judged to have decision-making capac-
ity by their physicians andwould probably bemaking such
decisions in routine clinical practice.
In conclusion, messages about the benefits of cancer
screening have been so effective that patients continue
screeningout of amoral obligationor even a custom.When
crafting messages to promote reconsideration of cancer
screening, clinicians shouldbe aware that discussions about
advanced age, statistics, and the recommendations of gov-
ernment panelsmay at best beunconvincing to older adults
andatworst diminish trust.Messages about increasing risks
and burdens of screening are likely to be more effective,
but because of deeply held beliefs about the benefits of
screening, messages delivered in a physician-patient en-
countermaynot be enough to changepatient practice.Cul-
tural and policy changes are also needed to modify the
widely accepted beliefs that favor screening at all times.
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